Sexual Health in Kidney Disease: The Conversation Nobody Has

What changes and why

In men, ED runs 50-70% on dialysis: vascular disease (the same calcification that hits arteries), low testosterone, high prolactin, uremic nerve and toxin effects, and medications. In women, kidney failure disrupts the hormonal axis — periods become irregular or stop, libido falls, and vaginal dryness appears; the psychological load (fatigue, body image, treatment burden) compounds everything.

Both directions matter: intimacy supports mental health and treatment adherence; sexual dysfunction worsens depression — a loop worth breaking explicitly.

What helps

For men: phosphodiesterase inhibitors (sildenafil, tadalafil) are effective in CKD with modest dose adjustment (tadalafil max 10 mg/day with CrCl <30); treat anemia and optimize dialysis; address depression. Testosterone replacement has a role in carefully selected men with confirmed deficiency (with monitoring — it affects fertility decisions and cardiovascular risk).

For women: vaginal moisturizers and lubricants for dryness; hormonal therapy decisions individualized (estrogen questions in CKD are nuanced); fertility counseling for those considering pregnancy — CKD pregnancy is possible but requires planning, and some transplant outcomes are affected by timing.

The conversation

The single biggest barrier is that nobody raises it — patients wait to be asked, and clinicians rarely ask. A direct, normalizing question — 'Kidney disease often affects sexual health; is that something you're dealing with?' — changes the care plan more than most lab values. Referral pathways: urology for men, gynecology and fertility specialists for women, and psychology for the couple.